Loading...
 

Πρόσφατες δημοσιεύσεις για ρευματικά νοσήματα και COVID-19

 

Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis


Ann Rheum Dis. 2020 Oct 13;annrheumdis-2020-218946. doi: 10.1136/annrheumdis-2020-218946. Online ahead of print


Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30305-2/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930305-2

Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print.


Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus

https://onlinelibrary.wiley.com/doi/10.1002/art.41450

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41450

Arthritis Rheumatol.2020 Jul 26. doi: 10.1002/art.41450. Online ahead of print.


Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis

https://onlinelibrary.wiley.com/doi/10.1002/art.41469

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41469

Putman M, et al. Arthritis Rheumatol. 2020. PMID: 32741139


Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays

https://www.sciencedirect.com/science/article/pii/S1472648320303187?via%3Dihub

https://www.rbmojournal.com/article/S1472-6483(20)30318-7/fulltext

 


Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

https://ard.bmj.com/content/79/9/1143?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=07082020

https://ard.bmj.com/content/annrheumdis/79/9/1143.full.pdf

Ramiro S, et al. Ann Rheum Dis. 2020. PMID: 32719045


Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

https://ard.bmj.com/content/early/2020/08/12/annrheumdis-2020-218296?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=15082020

https://ard.bmj.com/content/annrheumdis/early/2020/08/12/annrheumdis-2020-218296.full.pdf

Ann Rheum Dis.2020 Aug 12;annrheumdis-2020-218296. doi: 10.1136/annrheumdis-2020-218296. Online ahead of print.


COVID‐19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41456?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41456

Arthritis Rheumatol.2020 Jul 28. doi: 10.1002/art.41456. Online ahead of print.

 


Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

https://www.nature.com/articles/s41591-020-0965-6

https://www.nature.com/articles/s41591-020-0965-6.pdf

Nat Med.2020 Jun 18.doi: 10.1038/s41591-020-0965-6.Online ahead of print


Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

https://ard.bmj.com/content/early/2020/07/08/annrheumdis-2020-218259?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=14072020

https://ard.bmj.com/content/annrheumdis/early/2020/07/08/annrheumdis-2020-218259.full.pdf

Ann Rheum Dis. 2020 Jul 9;annrheumdis-2020-218259. doi: 10.1136/annrheumdis-2020-218259. Online ahead of print.


Tocilizumab for treatment of mechanically ventilated patients with COVID-19

https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa954/5870306

 


Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

https://ard.bmj.com/content/early/2020/06/30/annrheumdis-2020-218054?utm_source=alert&utm_medium=email&utm_campaign=ard&utm_content=latest&utm_term=06072020

https://ard.bmj.com/content/annrheumdis/early/2020/06/30/annrheumdis-2020-218054.full.pdf

Ann Rheum Dis. 2020 Jun 30;annrheumdis-2020-218054. doi: 10.1136/annrheumdis-2020-218054. Online ahead of print


Brief Report: Anti‐phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID‐19)

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41425?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41425

Arthritis Rheumatol. 2020 Jun 30. doi: 10.1002/art.41425. Online ahead of print.


Anti‐cardiolipin IgG autoantibodies are an independent risk factor of COVID‐19 severity

https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41409?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.41409

Arthritis Rheumatol. 2020 Jun 21;10.1002/art.41409. doi: 10.1002/art.41409. Online ahead of print.


Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30162-0/fulltext

https://www.thelancet.com/action/showPdf?pii=S2589-5370%2820%2930162-0

 


Perspectives of patients with rheumatic diseases in the early phase of COVID‐19

https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24347?campaign=wolacceptedarticle

https://onlinelibrary.wiley.com/doi/epdf/10.1002/acr.24347

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

https://ard.bmj.com/content/early/2020/06/11/annrheumdis-2020-217960

https://ard.bmj.com/content/annrheumdis/early/2020/06/11/annrheumdis-2020-217960.full.pdf

Ann Rheum Dis. 2020 Jun 11;annrheumdis-2020-217960. doi: 10.1136/annrheumdis-2020-217960. Online ahead of print.


Anakinra for severe forms of COVID-19: a cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30164-8/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930164-8

Published:May 29, 2020DOI:https://doi.org/10.1016/S2665-9913(20)30164-8


A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMoa2016638

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2016638?articleTools=true

PMID: 32492293 DOI: 10.1056/NEJMoa2016638


COVID-19 and systemic lupus erythematosus: a case series

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30161-2/fulltext

https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930161-2

Published Online May 26, 2020 https://doi.org/10.1016/ S2665-9913(20)30161-2


Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARSCoV-2 infection and severe COVID-19

https://ard.bmj.com/content/early/2020/05/20/annrheumdis-2020-217690

https://ard.bmj.com/content/annrheumdis/early/2020/05/20/annrheumdis-2020-217690.full.pdf

PMID: 32381561 DOI: 10.1136/annrheumdis-2020-217690


Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

https://ard.bmj.com/content/early/2020/05/29/annrheumdis-2020-217871

https://ard.bmj.com/content/annrheumdis/early/2020/05/29/annrheumdis-2020-217871.full.pdf

Ann Rheum Dis. 2020 May 29;annrheumdis-2020-217871. doi: 10.1136/annrheumdis-2020-217871. Online ahead of print


Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

https://ard.bmj.com/content/annrheumdis/early/2020/05/31/annrheumdis-2020-217935.full.pdf

Ann Rheum Dis. 2020 May 31;annrheumdis-2020-217935. doi: 10.1136/annrheumdis-2020-217935. Online ahead of print


Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

https://ard.bmj.com/content/early/2020/05/22/annrheumdis-2020-217627

https://ard.bmj.com/content/annrheumdis/early/2020/05/22/annrheumdis-2020-217627.full.pdf

Ann Rheum Dis: 2020 May 22;annrheumdis-2020-217627. doi: 10.1136/annrheumdis-2020-217627. Online ahead of print.


Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30127-2/fulltext

www.thelancet.com/rheumatology. Published online May 7, 2020 https://doi.org/10.1016/S2665-9913(20)30127-2


Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMc2013656

May 5, 2020 DOI: 10.1056/NEJMc2013656


Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMc2007575

N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.


Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York

https://www.nejm.org/doi/full/10.1056/NEJMc2009567?query=featured_home

N Engl J Med. 2020 Apr 29. doi: 10.1056/NEJMc2009567. [Epub ahead of print]


Effective treatment of severe COVID-19 patients with tocilizumab

https://www.pnas.org/content/pnas/early/2020/04/27/2005615117.full.pdf

PNAS first published April 29, 2020 https://doi.org/10.1073/pnas.2005615117


Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis

http://www.jrheum.org/content/jrheum/early/2020/04/24/jrheum.200507.full.pdf

J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507. [Epub ahead of print]


Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 

https://ard.bmj.com/content/79/5/667.long

Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.


Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine 

https://ard.bmj.com/content/early/2020/04/24/annrheumdis-2020-217566

Ann Rheum Dis. 2020 Apr 24. pii: annrheumdis-2020-217566. doi: 10.1136/annrheumdis-2020-217566. [Epub ahead of print]


Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. 

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30095-3/fulltext 

Lancet Rheumatol. 2020 Apr 16. doi: 10.1016/S2665-9913(20)30095-3. [Epub ahead of print]


Recomendations Regarding COVID-19 Infection in Rheumatic Patients in Greece

https://mjrheum.org/current-issue/newsid792/204, Published 31 Mar 2020

Mediterr J Rheumatol 2020;31(1):6-7

 

Ελληνική Ρευματολογική Εταιρεία
& Επαγγελματική Ένωση
Ρευματολόγων Ελλάδας

Ακολουθήστε μας:                  Linkedin
© 2015-2020 ΕΛΛΗΝΙΚΗ ΡΕΥΜΑΤΟΛΟΓΙΚΗ ΕΤΑΙΡΕΙΑ - ALL RIGHTS RESERVED.